4 institute for clinical pharmacology & safety English-speaking jobs in Zofingen
Include languages [+] sorted by: relevance · newest
Global Head Drug Product Development & Technology
- Siegfried Ltd
- Zofingen
- June 1
a trusted and respected partner to the pharmaceutical industry, we uphold the highest standards in safety ... drive the advancement of Siegfried’s DP technologies and development project performance across all clinical ... )* Proven track record of advancing OSD and/or parenteral programs from **early development through clinical ... Development* With demonstrated track record advancing development programs **from early research through clinical ... The role includes evaluating new customer development requests for formulation and process development
Head of Sales & Business Development Drug Products
- Siegfried AG
- Zofingen
- June 8
a trusted and respected partner to the pharmaceutical industry, we uphold the highest standards in safety ... and evaluate new market opportunities, emerging trends, and customer needs in the drug product space (clinical ... Your Role The Global Head of Sales and Business Development for Drug Products is responsible for leading ... Strategic Leadership Define and execute the global sales strategy for the drug product business unit, ... capabilities meet customer demand Financial Management Own global revenue targets and sales budget for
Intern Commercial Excellence
- Siegfried AG
- Zofingen
- June 26
a trusted and respected partner to the pharmaceutical industry, we uphold the highest standards in safety ... Your Profile: What are we looking for? ... Your Role: At Siegfried we are currently looking for an Intern Commercial Excellence to join our team ... Furthermore, you will support preparation of management presentation for different target audiences. ... take the innovations of our pharmaceutical customers to industrial scale and manufacture safe drugs for
Future Talent Program 2026 - Expression of Interest (Europe, Greater Middle East & Africa)
- Tetra Pak
- Zofingen
- May 8
- 1
- 1



















































































































































